*September 2021*
EGFR Resisters co-founder Jill Feldman presented how stigmatizing words can affect patients and their families at WCLC 2021. Watch the video presentation here.
*September 2021*
EGFR Resisters co-founder Jill Feldman presented how stigmatizing words can affect patients and their families at WCLC 2021. Watch the video presentation here.





The EGFR Resisters is a global community of patients and caregivers impacted by EGFR-positive lung cancer. We’re here to share knowledge, offer support and collaborate to drive progress in research and care. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.

